[go: up one dir, main page]

WO2009140466A3 - Linezolid co-crystals - Google Patents

Linezolid co-crystals Download PDF

Info

Publication number
WO2009140466A3
WO2009140466A3 PCT/US2009/043903 US2009043903W WO2009140466A3 WO 2009140466 A3 WO2009140466 A3 WO 2009140466A3 US 2009043903 W US2009043903 W US 2009043903W WO 2009140466 A3 WO2009140466 A3 WO 2009140466A3
Authority
WO
WIPO (PCT)
Prior art keywords
linezolid
crystals
preparing
processes
crystal former
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/043903
Other languages
French (fr)
Other versions
WO2009140466A2 (en
Inventor
Surya Narayana Devarakonda
Ram Thaimattam
Vamsee Krishna Muppidi
Sundara Lakshmi Kanniah
Naga Kiran Duggirala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of WO2009140466A2 publication Critical patent/WO2009140466A2/en
Publication of WO2009140466A3 publication Critical patent/WO2009140466A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Co-crystals of linezolid, comprising linezolid and a co-crystal former, and processes for preparing them.
PCT/US2009/043903 2008-05-14 2009-05-14 Linezolid co-crystals Ceased WO2009140466A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1187/CHE/2008 2008-05-14
IN1187CH2008 2008-05-14
US7634408P 2008-06-27 2008-06-27
US61/076,344 2008-06-27

Publications (2)

Publication Number Publication Date
WO2009140466A2 WO2009140466A2 (en) 2009-11-19
WO2009140466A3 true WO2009140466A3 (en) 2010-03-04

Family

ID=41319332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/043903 Ceased WO2009140466A2 (en) 2008-05-14 2009-05-14 Linezolid co-crystals

Country Status (1)

Country Link
WO (1) WO2009140466A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011029460A1 (en) * 2009-09-09 2011-03-17 Synthon B.V. Nonhygroscopic linezolid salts
WO2011050826A1 (en) * 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
BR112012010597B8 (en) * 2009-11-06 2022-07-19 Basf Se CRYSTALLINE COMPLEX, PROCESS FOR PREPARING THE CRYSTALLINE COMPLEX, AGRICULTURAL FORMULATION, METHOD TO CONTROL PHYTOPATOGENIC FUNGI, METHOD TO IMPROVE HEALTH OF PLANTS, METHOD FOR PROTECTING PLANT PROPAGATION MATERIAL AGAINST PESTS, METHOD TO REGULATE PLANT GROWTH AND COATED PLANT PROPAGATION
EA031237B1 (en) * 2013-07-29 2018-12-28 Ле Лаборатуар Сервье Novel complexes of agomelatine and sulphonic acids, process for their preparation and pharmaceutical compositions that contain them

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
WO2005035530A1 (en) * 2003-10-16 2005-04-21 Symed Labs Limited A novel crystalline form of linezolid
WO2006110155A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof
US20070015753A1 (en) * 2005-07-15 2007-01-18 Glenmark Pharmaceuticals Limited Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
WO2007026369A1 (en) * 2005-08-29 2007-03-08 Symed Labs Limited A novel amorphous form of linezolid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
WO2005035530A1 (en) * 2003-10-16 2005-04-21 Symed Labs Limited A novel crystalline form of linezolid
WO2006110155A1 (en) * 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof
US20070015753A1 (en) * 2005-07-15 2007-01-18 Glenmark Pharmaceuticals Limited Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
WO2007026369A1 (en) * 2005-08-29 2007-03-08 Symed Labs Limited A novel amorphous form of linezolid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MACCARONI, E. ET AL.: "Polymorphism of linezolid: A combined single-cystal, powder diffraction and NMR study", INTERNATIONAL JOURNAL OF PHARMACEUTICS., vol. 351, no. 1-2, 2008, pages 144 - 151 *

Also Published As

Publication number Publication date
WO2009140466A2 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
MX2012012627A (en) Processes for preparing linezolid.
WO2012014076A3 (en) Liver organoid, uses thereof and culture method for obtaining them
WO2013052913A3 (en) Methods and processes for non-invasive assessment of genetic variations
WO2012084126A3 (en) Formulation of lacosamide
SMT201700605T1 (en) Method for preparing tissue, particularly adipose tissue.
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
WO2012059441A3 (en) Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes
WO2011060213A3 (en) Preparation of sitagliptin and salts thereof
GEP20156397B (en) Process for the preparation of a rivaroxaban and intermediates formed in said process
WO2011025932A3 (en) Preparation of sitagliptin and salts thereof
WO2011139886A3 (en) Preparation of febuxostat
WO2011157390A3 (en) Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
WO2012131707A3 (en) Crystalline form of bortezomib, preparation method and pharmaceutical composition there f
WO2009140466A3 (en) Linezolid co-crystals
WO2010034976A3 (en) Co-crystals
EP2883870B8 (en) Method for producing 1,4-benzoxazine compound
WO2011095269A3 (en) Directly compressible magnesium hydroxide carbonate
WO2010117979A3 (en) Serotonin and norepinephrine reuptake inhibitor
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
EP2665703A1 (en) Lauflumide and the enantiomers thereof, method for preparing same and therapeutic uses thereof
MX349563B (en) Pharmaceutical formulation of nanonised fenofibrate.
WO2009114685A3 (en) O-desmethylvenlafaxine salts
IL208019A0 (en) Process for the preparation of 2-amino-2-[2-(4-c3-c21-alkyl-phenyl) ethyl) propane-1, 3-diols
EP2634183B8 (en) Method for preparing 1,3,5-trioxane
EP2634182B8 (en) Method for preparing 1,3,5-trioxane

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09747548

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09747548

Country of ref document: EP

Kind code of ref document: A2